Docetaxel for hormone-refractory prostate cancer

Lancet. 2008 Oct 25;372(9648):1461; author reply 1461-2. doi: 10.1016/S0140-6736(08)61616-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Clinical Trials as Topic
  • Docetaxel
  • Humans
  • Male
  • Multicenter Studies as Topic
  • Prostatic Neoplasms / drug therapy*
  • Taxoids / administration & dosage
  • Taxoids / therapeutic use*
  • Treatment Outcome

Substances

  • Taxoids
  • Docetaxel